Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

Novel cardiovascular risk markers in women with ischaemic heart disease

Dana Pop1, Alexandra Dădârlat2, D Zdrenghea2

  • 1University of Medicine and Pharmacy Iuliu HaŢieganu, Cluj-Napoca, Romania. ale_dadarlat@yahoo.com.

Cardiovascular Journal of Africa
|July 8, 2014
PubMed

Insights

Premenopausal women have lower coronary heart disease rates due to hormones, but higher mortality. Novel cardiovascular risk biomarkers are crucial as traditional factors underestimate risk in females, particularly concerning microvascular angina.

Area of Science:

  • Cardiology
  • Biomarkers
  • Women's Health

Background:

  • Coronary heart disease (CHD) incidence is lower in premenopausal women than men due to hormonal protection, with angina occurring ~10 years later.
  • Despite lower incidence, women exhibit higher mortality from ischaemic heart disease compared to men.
  • Traditional cardiovascular risk factors and assessment scores appear to underestimate risk in females.

Purpose of the Study:

  • To investigate novel cardiovascular risk biomarkers in women.
  • To understand the role of these biomarkers in endothelial dysfunction and inflammation.
  • To address the underestimation of cardiovascular risk in females by traditional factors.

Main Methods:

  • Focus on novel cardiovascular risk biomarkers.
  • Classification of novel markers into inflammatory markers, haemostasis markers, and other biomarkers.
  • Analysis of plasma levels of established biomarkers.

Main Results:

  • Increased plasma levels of novel risk biomarkers are associated with worsened endothelial dysfunction.
  • These biomarkers are linked to inflammation, a key factor in microvascular angina pathogenesis.
  • Microvascular angina is particularly prevalent in women.

Conclusions:

  • Novel cardiovascular risk biomarkers are essential for accurate risk assessment in women.
  • Understanding these biomarkers can improve the management of ischaemic heart disease in females.
  • Targeting endothelial dysfunction and inflammation may be key in preventing cardiovascular events in women.

More Related Videos

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients09:08

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

217
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
616
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K